Zobrazeno 1 - 10
of 16
pro vyhledávání: '"D. H. Ashwath Narayana"'
Autor:
D. H. Ashwath Narayana
Publikováno v:
RGUHS National Journal of Public Health, Vol 9, Iss 3 (2024)
None
Externí odkaz:
https://doaj.org/article/8f033f0fdd88492185dc8bf675bc0cdb
Autor:
Ravish S. Haradanhalli, Nitu Kumari, Mysore K. Sudarshan, D. H. Ashwath Narayana, Ramya M. Prashanth, Jithin Surendran
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 12, Pp 5355-5360 (2021)
WHO recommends infiltration of rabies immunoglobulins/rabies monoclonal antibodies as anatomically possible, into or close to all category III animal bite wound(s)/exposures for post exposure prophylaxis. The volume required for wound infiltration de
Externí odkaz:
https://doaj.org/article/44b9599f216144808c4a1725775c9b7d
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
The human rabies immunoglobulin (HRIG) is a life-saving immune biological essential for all category III animal exposures. It provides neutralizing antibodies at the site of exposure until the body can produce vaccine-mediated antibodies. We conducte
Externí odkaz:
https://doaj.org/article/dc7399519dbb41228ff36803e265ca15
Autor:
K M Chaitra, Sandeep Ballal, N R Ramesh Masthi, D H Ashwath Narayana, H T Yashodha, Mansi Kumar, Afroza Asiya, Divya Bharathi G, Sanjay S C
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 2, p e0009045 (2021)
We report a case of rabies encephalitis in a 4½-year-old male child with an exposure to a suspect rabid dog. The child developed rabies 25 days after receiving postexposure prophylaxis. Rabies immunoglobulin (RIG) is currently administered according
Externí odkaz:
https://doaj.org/article/b2d5e2ebe4504defa90f6b65af735dae
Publikováno v:
INDIAN JOURNAL OF APPLIED RESEARCH. :50-52
Introduction: According to WHO, immunization interventions have proven to be a success across the globe and today reach out to over 100 million children and prevent 2.5 million deaths per year. As new global health paradigms emerge, fresh perspective
Publikováno v:
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. :77-79
Background: Vaccination is a vital component of the public health programs and among most cost effective medical intervention. Vaccines are usually safe and effective. However, like any other pharmaceutical products, adverse events may occur occasion
Autor:
Nithya J Gogtay, Prasad S. Kulkarni, Peter S. Cheslock, Rajeev M. Dhere, Varsha Parulekar, B J Mahendra, D H Ashwath Narayana, B R Harish, William C. Blackwelder, Deborah C. Molrine, Renuka Munshi, Dipti Kumbhar, Sambhaji Shankar Pisal, Sunil Karande, Saket J. Thaker, Vikas D. Kshirsagar, Bhagwat Gunale, H S Ravish, Siddharth P Deshpande, Susan M. Moore
Publikováno v:
Clinical Infectious Diseases. 66:387-395
Background Lack of access to rabies immunoglobulin (RIG) contributes to high rabies mortality. A recombinant human monoclonal antibody (SII RMAb) was tested in a postexposure prophylaxis (PEP) regimen in comparison with a human RIG (HRIG)-containing
Autor:
D H Ashwath Narayana, D. Lobo, M.K. Sudarshan, Naveen G. Rao, F.-X. Meslin, B J Mahendra, Gangaboraiah, K. Ravikumar, Shampur Narayan Madhusudana, S. Abdul Rahman
Publikováno v:
International Journal of Infectious Diseases. 11:29-35
SummaryObjectiveHuman rabies has been endemic in India since time immemorial, and the true incidence of the disease and nationwide epidemiological factors have never been studied. The main objectives of the present study were to estimate the annual i
Publikováno v:
International Journal Of Community Medicine And Public Health. 4:396
Background: Animal bites are a major public health problem in our country. Pre-exposure vaccination using cell culture vaccines is a safe and effective method of preventing rabies and is recommended for anyone who will be at continual, frequent or in
Autor:
Thitamaranahalli V. Sanjay, D H Ashwath Narayana, G.M. Venkatesh, B J Mahendra, M.K. Sudarshan, M.S. Ananda Giri, H S Ravish
Publikováno v:
Human Vaccines. 3:87-89
Fourteen pregnant women who received rabies post-exposure prophylaxis (PEP) at the anti-rabies clinic (ARC) of Kempegowda Institute of Medical Sciences (KIMS) were followed up for assessing the safety of modern rabies vaccines and equine rabies immun